Karen L Rascati (Karen Rascati)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Topics

Combination Therapy

Sickle Cell Disease

Decision Making

Major Depressive Disorder

Top Venues

Clinical drug investigation

Postgraduate medicine

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Ryan Thaliffdeen, Anthony Yu, Karen L Rascati
Cost-Effectiveness Evaluation of Oral CGRP Antagonists, Atogepant and Rimegepant, for the Preventative Treatment of Episodic Migraine: Results from a US Societal Perspective Model. Clinical drug investigation 44 (3) (2024)
Ryan Thaliffdeen, Anthony Yu, Karen L Rascati
Cost-Effectiveness Evaluation of Oral CGRP Antagonists, Atogepant and Rimegepant, for the Preventative Treatment of Episodic Migraine: Results from a US Societal Perspective Model. Clinical drug investigation (2024)
Ryan Thaliffdeen, Anthony Yu, Karen L Rascati
Cost-Effectiveness Evaluation of Oral CGRP Antagonists, Atogepant and Rimegepant, for the Preventative Treatment of Episodic Migraine: Results from a US Societal Perspective Model. Clinical drug investigation 44 (3) (2024)
Anthony Yu, Alexandra Ritenour, Jennifer Vincent, Chanhyun Park, Karen L Rascati, Paul J Godley
Exploring factors related to clinically advanced fibrosis in patients with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis. Postgraduate medicine (2023)
Hyeun Ah Kang, Jamie C Barner, Kenneth A Lawson, Karen L Rascati, Robert C Mignacca
Impact of adherence to hydroxyurea on health outcomes among patients with sickle cell disease. American journal of hematology (2022)
Benjamin Wong, Yalin Deng, Karen L Rascati
Healthcare Utilization, Costs, and Adverse Events of Real-Time Continuous Glucose Monitoring (rtCGM) versus Traditional Blood Glucose Monitoring (BG) among US Adults with Type 1 Diabetes. Journal of diabetes science and technology (2021)
Chris LaVallee, Karen L Rascati, Tyler H Gums
Antihypertensive agent utilization patterns among patients with uncontrolled hypertension in the United States. Journal of clinical hypertension (Greenwich, Conn.) 22 (11) (2020)
Catlin Grisham-Takac, Phillip Lai, Maaya Srinivasa, Lindsay Vasquez, Karen L Rascati
Correlation of antidepressant target dose optimization and achievement of glycemic control. The mental health clinician 9 (1) (2019)
Karen L Rascati
Comment on: "Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode". Drugs in R&D 17 (3) (2018)